In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.
If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
In the aftermath of a divorce, the relationship of minor children and their grandparents can often be the source of sign... Read More
In the aftermath of virtually every car accident, there’s a critical question: who caused the crash? Who will be legal... Read More
After an accident, memories can fade, witnesses may relocate or even die, and crucial evidence can disappear or become d... Read More
How It Works